Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline A Austin

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|October 24, 2021
Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Topoisomerase II Chromatin ImmunoprecipitationKayleigh A Smith, Ian G Cowell, Caroline A Austin
Mutagenesis|November 12, 2010
An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assayIan G Cowell, Michael J Tilby, Caroline A Austin
Molecular Pharmacology|May 4, 2021
A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
International Journal of Molecular Sciences|October 14, 2023
To Break or Not to Break: The Role of TOP2B in TranscriptionIan G Cowell, John W Casement, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2025
Topoisomerase II DNA Cleavage Assay Using Fluorescently Labelled Double-Stranded OligonucleotidesIan G Cowell, Elise M Ling, Caroline A Austin
Biochemical Pharmacology|May 30, 2002
Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cellsElaine Willmore, Fiona Errington, Michael J Tilby, et al.
FEBS Letters|November 5, 2003
Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonanceChrysoula Leontiou, Robert Lightowlers, Jeremy H Lakey, et al.
Molecular Pharmacology|December 16, 2016
Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer ChemotherapyMandeep Atwal, Emma L Lishman, Caroline A Austin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaksLisa M Smith, Elaine Willmore, Caroline A Austin, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|October 24, 2021
Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Topoisomerase II Chromatin ImmunoprecipitationKayleigh A Smith, Ian G Cowell, Caroline A Austin
Mutagenesis|November 12, 2010
An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assayIan G Cowell, Michael J Tilby, Caroline A Austin
Molecular Pharmacology|May 4, 2021
A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent ComplexesRebecca L Swan, Ian G Cowell, Caroline A Austin
International Journal of Molecular Sciences|October 14, 2023
To Break or Not to Break: The Role of TOP2B in TranscriptionIan G Cowell, John W Casement, Caroline A Austin
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2025
Topoisomerase II DNA Cleavage Assay Using Fluorescently Labelled Double-Stranded OligonucleotidesIan G Cowell, Elise M Ling, Caroline A Austin
Biochemical Pharmacology|May 30, 2002
Formation and longevity of idarubicin-induced DNA topoisomerase II cleavable complexes in K562 human leukaemia cellsElaine Willmore, Fiona Errington, Michael J Tilby, et al.
FEBS Letters|November 5, 2003
Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonanceChrysoula Leontiou, Robert Lightowlers, Jeremy H Lakey, et al.
Molecular Pharmacology|December 16, 2016
Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer ChemotherapyMandeep Atwal, Emma L Lishman, Caroline A Austin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaksLisa M Smith, Elaine Willmore, Caroline A Austin, et al.
Pageof 8